Intratumoral CAVATAK (CVA21) and Ipilimumab in Patients With Advanced Melanoma (VLA-013 MITCI)
Clinical trial NCT02307149 · COMPLETED
Trial details
- NCT number
- NCT02307149
- Sponsor
- Viralytics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-05
- Primary completion
- 2019-11-05
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.